Company
GermanyPublic company, NYSE: ABTAbbott Laboratories GmbH (NYSE: ABT), Neustadt am Rubenberge, Germany – FDA Inspections
Inspection records and compliance data for Abbott Laboratories GmbH in Neustadt am Rubenberge. 7 FDA inspections on record, 1 Form 483, last inspected May 30, 2024. Publicly traded as NYSE: ABT.
Company Profile
This profile covers Abbott Laboratories GmbH based in Neustadt am Rubenberge, Germany.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 3
- NAI
- 4
- Form 483s
- 1
- Warning letters
- 0
First inspected October 14, 2008. Last inspected May 30, 2024.
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 30, 2024 | VAI | Human Drugs · Drug Quality Assurance | 1274874 |
| August 30, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1107966 |
| February 24, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1017658 |
| October 24, 2014 | NAI | Human Drugs · Drug Quality Assurance | 904481 |
| April 19, 2013 | NAI | Human Drugs · Drug Quality Assurance | 830369 |
| June 11, 2010 | NAI | Human Drugs · Drug Quality Assurance | 682154 |
| October 14, 2008 | VAI | Human Drugs · Drug Quality Assurance | 548334 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Abbott Laboratories GmbH
Stock ticker
ABT
Exchange
NYSE
Share price
$113.74
Market cap
$197.0B
Price as of
November 6, 2026
FEI Number
3002808216
Address
Justus-von-Liebig-Str. 33, Neustadt am Rubenberge, Germany
Country
Germany
ID: 17787c23-b813-4947-af85-5019aabd6b67